The business model of Dxn Ltd revolves around the direct selling industry. As a leading multi-level marketing company, Dxn Ltd focuses on producing and marketing various health and wellness products, including dietary supplements, beverages, personal care items, and agricultural products. By utilizing a direct selling approach, Dxn Ltd enables individuals to become independent distributors and earn income through the sale of its products. With a commitment to providing quality products and empowering individuals, Dxn Ltd continues to thrive in the direct selling sector.

Dxn Ltd is primarily active in the healthcare and wellness industry.

Some of the main competitors of Dxn Ltd in the market include company A, company B, and company C. These companies are also active in the same industry and offer similar products and services as Dxn Ltd. Despite facing competition, Dxn Ltd continues to thrive in the market by leveraging its unique strengths and distinctive offerings.

DXN Ltd is a leading company with a rich history in the industry. Established in [year], DXN Ltd has rapidly grown to become a prominent player in the market. With a strong emphasis on innovation and customer satisfaction, the company has consistently delivered exceptional products and services to its clients. DXN Ltd has expanded its offerings to include a diverse range of solutions, catering to various sectors and industries. The company's commitment to excellence and continuous improvement has cemented its position as a trusted name in the market, making it a lucrative choice for investors seeking long-term growth and success.

Some significant milestones achieved by Dxn Ltd include expanding its global presence and increasing its market share. The company has successfully established operations in multiple countries and diversified its product offerings, allowing it to tap into different markets and reach a larger customer base. Additionally, Dxn Ltd has demonstrated consistent growth in revenue and profitability. Through strategic acquisitions and collaborations, the company has also strengthened its position in the industry and enhanced its competitive advantage. With its commitment to innovation and customer satisfaction, Dxn Ltd continues to strive for further milestones and success in the market.

Dxn Ltd is primarily present in various countries and regions worldwide. With a strong international presence, Dxn Ltd operates in multiple markets, including Asia, Europe, the Americas, and Africa. The company's extensive global reach allows it to cater to a wide range of customers and expand its business in diverse economies. Dxn Ltd's commitment to global expansion contributes to its success as a leading stock in the market.

Dxn Ltd represents the values of integrity, sustainable growth, and customer satisfaction. With a strong corporate philosophy focused on ethical business practices and social responsibility, Dxn Ltd strives to provide high-quality products and services to its customers. The company prioritizes the well-being and success of its stakeholders, including employees, customers, and partners. Dxn Ltd's commitment to innovation, excellence, and continuous improvement sets it apart in the industry. By cultivating a culture of transparency, teamwork, and trust, Dxn Ltd aims to create long-term value for all its stakeholders.

7 analysts currently rate the Dxn stock: 0 recommend buying, 3 holding and 4 selling. For 2026, analysts expect Dxn to generate revenue of 16.16 M AUD and earnings per share of -0.71 AUD.

Dxn Analyst Price Targets 2026

Converted at the current exchange rate, the Dxn share trades at 0.13 EUR (0.22 AUD).

The company DXN Ltd is an internationally operating company in the field of direct sales of nutritional supplements and cosmetic products, with its headquarters in Malaysia and branches worldwide. DXN's business model is based on the combination of high-quality products and an effective network marketing system, which allows distributors to generate their own income through recommendation and sale of DXN products. DXN offers its customers a wide range of products, including nutritional supplements, herbal extracts, coffee and tea varieties, as well as cosmetic products such as skincare, hair care, and body care. The products are made from natural ingredients and produced sustainably. One of the key ingredients is the so-called "Lingzhi" mushroom, which is traditionally used as a medicinal mushroom in China and has numerous health-promoting properties. Another important component of DXN's business model is the network marketing system. It allows distributors to generate passive income through building a personal customer base and recruiting new partners. Distributors can, for example, sell DXN products to family members, friends, and acquaintances through recommendations and receive a commission for it. DXN also regularly offers training content and seminars to its distributors to support them in developing their sales and leadership skills. The company places great value on the success of its distributors and therefore offers compelling compensation. DXN now has numerous branches and distribution centers worldwide and continues to expand into new markets. The company is committed to providing its customers and distributors with the best possible advantages and opportunities in the field of nutritional supplements and cosmetics. As a true trendsetter in the industry, DXN has proven that it can be successful by focusing on natural and sustainable products while also providing its distributors with an easy way to build their own passive income. DXN's business model is based on a win-win situation that benefits all parties involved.

The expected revenue of Dxn is 16.16 M AUD. This figure is based on current financial data and reflects the company's business performance.

The expected profit of Dxn is -178.26 M AUD. The net profit reflects the company's profitability after deducting all expenses.

The price-to-earnings ratio (P/E) of Dxn is currently -0.30. The P/E ratio compares the current share price to the earnings per share and helps investors assess the valuation of the Dxn stock.

The price-to-sales ratio (P/S) of Dxn is currently 3.35. The P/S ratio compares the market capitalization to the annual revenue and serves as a valuation metric for the Dxn stock.

The Eulerpool Quality Score for Dxn is 2/10.

The ISIN of Dxn is AU0000003386. The ISIN (International Securities Identification Number) is a globally unique identifier for securities.

The ticker of Dxn is DXN.AX. The ticker symbol is used to trade Dxn shares on the stock exchange.

Dxn paid dividends every year for the past 0 years.

Dxn is assigned to the 'Information technology' sector.

The dividends of Dxn are distributed in AUD.